MM
TEVA icon

MQS Management’s Teva Pharmaceuticals TEVA Stock Holding History

MQS Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,658
Closed -$178K – 618
2023
Q2 		$178K Buy
23,658
+2,378
+11% +$19.3K 0.12% 345
2023
Q1 		$188K Buy
+21,280
New +$210K 0.12% 355
2022
Q3 		– Sell
-11,797
Closed -$89K – 580
2022
Q2 		$89K Buy
+11,797
New +$103K 0.06% 356

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

MQS Management's TEVA Position: Q3 2023 in Review

MQS Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2023, closing a stake of 23,658 shares — an estimated $178K sold.

MQS Management first reported a position in TEVA in Q2 2022 and held it in 3 quarters. The position peaked at $188K in Q1 2023. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • MQS Management reported no remaining Teva Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • MQS Management sold 23,658 Teva Pharmaceuticals shares in Q3 2023, an estimated $178K.
  • MQS Management first reported a position in Teva Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • MQS Management's Teva Pharmaceuticals position peaked at $188K in Q1 2023.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on MQS Management's 13F filing for Q3 2023, filed 13 Nov 2023.